Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$11.23 - $19.59 $2.81 Million - $4.9 Million
250,000 Added 250.0%
350,000 $4.83 Million
Q1 2021

May 17, 2021

BUY
$19.33 - $37.75 $1.93 Million - $3.78 Million
100,000 New
100,000 $2.31 Million
Q3 2020

Nov 16, 2020

SELL
$39.09 - $53.44 $5.86 Million - $8.02 Million
-150,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$46.7 - $92.04 $4.67 Million - $9.2 Million
100,000 Added 200.0%
150,000 $7.19 Million
Q1 2020

May 15, 2020

SELL
$48.35 - $118.68 $720,415 - $1.77 Million
-14,900 Reduced 22.96%
50,000 $3.15 Million
Q4 2019

Jan 31, 2020

BUY
$57.36 - $124.1 $3.72 Million - $8.05 Million
64,900 New
64,900 $8.04 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.